Co-Diagnostics Files 2024 10-K

Ticker: CODX · Form: 10-K · Filed: Mar 27, 2025 · CIK: 1692415

Co-Diagnostics, Inc. 10-K Filing Summary
FieldDetail
CompanyCo-Diagnostics, Inc. (CODX)
Form Type10-K
Filed DateMar 27, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, medical-devices

TL;DR

CODX filed its 2024 10-K. Full financials and biz details inside.

AI Summary

Co-Diagnostics, Inc. filed its 2024 10-K on March 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Utah, operates in the surgical and medical instruments sector. Key financial data and business operations for the period are detailed within the filing.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Co-Diagnostics, Inc.'s financial performance and business activities for the fiscal year 2024, enabling informed decision-making.

Risk Assessment

Risk Level: medium — As a medical device company, Co-Diagnostics, Inc. is subject to regulatory risks, market competition, and potential shifts in healthcare spending.

Key Players & Entities

  • Co-Diagnostics, Inc. (company) — Filer of the 10-K
  • 2024-12-31 (date) — Fiscal year end
  • 2025-03-27 (date) — Filing date
  • 4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY, UT 84124 (address) — Company business and mailing address
  • 8012789769 (phone_number) — Company business phone

FAQ

What was Co-Diagnostics, Inc.'s total revenue for the fiscal year ending December 31, 2024?

The filing indicates ProductRevenueMember and GrantRevenueMember for 2024, but specific total revenue figures are not provided in this excerpt.

When did Co-Diagnostics, Inc. file its 10-K report for the fiscal year 2024?

Co-Diagnostics, Inc. filed its 10-K report on March 27, 2025.

What is the primary business of Co-Diagnostics, Inc. according to the SIC code?

The Standard Industrial Classification (SIC) code for Co-Diagnostics, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Where is Co-Diagnostics, Inc. headquartered?

Co-Diagnostics, Inc. is headquartered in Salt Lake City, Utah, with its business and mailing address listed as 4049 South Highland Drive, Salt Lake City, UT 84124.

What is the SEC file number for Co-Diagnostics, Inc.'s 10-K filing?

The SEC file number for Co-Diagnostics, Inc.'s 10-K filing is 001-38148.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding Co-Diagnostics, Inc. (CODX).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.